Endo Revenue 2006-2019 | ENDP

Endo revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Endo Annual Revenue
(Millions of US $)
2018 $2,947
2017 $3,469
2016 $4,010
2015 $3,269
2014 $2,381
2013 $2,125
2012 $2,816
2011 $2,525
2010 $1,716
2009 $1,461
2008 $1,261
2007 $1,086
2006 $910
2005 $820
Endo Quarterly Revenue
(Millions of US $)
Q2 2019 $700
Q1 2019 $720
Q4 2018 $786
Q3 2018 $745
Q2 2018 $715
Q1 2018 $701
Q4 2017 $769
Q3 2017 $787
Q2 2017 $876
Q1 2017 $1,038
Q4 2016 $1,242
Q3 2016 $884
Q2 2016 $921
Q1 2016 $964
Q4 2015 $1,074
Q3 2015 $746
Q2 2015 $735
Q1 2015 $714
Q4 2014 $663
Q3 2014 $654
Q2 2014 $593
Q1 2014 $471
Q4 2013 $93
Q3 2013 $661
Q2 2013 $712
Q1 2013 $658
Q4 2012 $589
Q3 2012 $750
Q2 2012 $785
Q1 2012 $691
Q4 2011 $598
Q3 2011 $759
Q2 2011 $608
Q1 2011 $560
Q4 2010 $511
Q3 2010 $444
Q2 2010 $397
Q1 2010 $364
Q4 2009 $391
Q3 2009 $361
Q2 2009 $373
Q1 2009 $335
Q4 2008 $347
Q3 2008 $317
Q2 2008 $306
Q1 2008 $290
Q4 2007 $305
Q3 2007 $269
Q2 2007 $257
Q1 2007 $254
Q4 2006 $259
Q3 2006 $217
Q2 2006 $228
Q1 2006 $205
Q4 2005 $241
Q3 2005 $245
Q2 2005 $196
Q1 2005 $138
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.810B $2.947B
Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.846B 37.47
Takeda Pharmaceutical (TAK) Japan $53.241B 8.33
Astellas Pharma (ALPMY) Japan $28.433B 13.55
Merck (MKGAF) Germany $14.488B 19.77
Eisai (ESALY) Japan $14.130B 21.63
UCB SA (UCBJF) Belgium $13.839B 0.00
Grifols, S.A (GRFS) Spain $13.744B 17.53
Ono Pharmaceutical (OPHLF) Japan $9.212B 19.69
Ionis Pharmaceuticals (IONS) United States $8.725B 18.82
Neurocrine Biosciences (NBIX) United States $8.110B 0.00
IPSEN SA ADR (IPSEY) France $7.776B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 0.00
Sage Therapeutics (SAGE) United States $7.024B 0.00
Catalent (CTLT) United States $6.972B 27.56
Jazz Pharmaceuticals (JAZZ) Ireland $6.679B 8.79
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.026B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.083B 18.27
United Therapeutics (UTHR) United States $3.541B 0.00
FibroGen (FGEN) United States $3.185B 79.67
Evotec AG (EVTCY) Germany $3.183B 43.58
Arrowhead Pharmaceuticals (ARWR) United States $3.034B 69.57
Taro Pharmaceutical Industries (TARO) Israel $2.869B 10.28
Nektar Therapeutics (NKTR) United States $2.827B 0.00
PTC Therapeutics (PTCT) United States $2.116B 0.00
Tilray (TLRY) Canada $2.016B 0.00
Xencor (XNCR) United States $1.925B 41.97
Portola Pharmaceuticals (PTLA) United States $1.793B 0.00
Zogenix (ZGNX) United States $1.779B 0.00
Corcept Therapeutics (CORT) United States $1.587B 21.81
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.543B 15.48
Pacira Pharmaceuticals (PCRX) United States $1.531B 55.71
Heron Therapeutics (HRTX) United States $1.413B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.341B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.147B 18.92
Radius Health (RDUS) United States $1.123B 0.00
ArQule (ARQL) United States $1.050B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.008B 0.00
TherapeuticsMD (TXMD) United States $0.931B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.864B 3.85
Spectrum Pharmaceuticals (SPPI) United States $0.820B 0.00
Aerie Pharmaceuticals (AERI) United States $0.814B 0.00
Dova Pharmaceuticals (DOVA) United States $0.813B 0.00
Organogenesis Holdings (ORGO) United States $0.676B 0.00
Karyopharm Therapeutics (KPTI) United States $0.619B 0.00
Concordia (CXRXF) Canada $0.615B 0.00
Flexion Therapeutics (FLXN) United States $0.505B 0.00
Akebia Therapeutics (AKBA) United States $0.492B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.478B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.470B 0.00
Translate Bio (TBIO) United States $0.457B 0.00
ChemoCentryx (CCXI) United States $0.448B 0.00
Lannett Co Inc (LCI) United States $0.448B 4.72
Siga Technologies (SIGA) United States $0.447B 1.04
Indivior (INVVY) United States $0.444B 1.61
Innate Pharma SA (IPHYF) France $0.410B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.400B 0.00
Collegium Pharmaceutical (COLL) United States $0.398B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.396B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.373B 16.98
ImmunoGen (IMGN) United States $0.351B 0.00
DURECT (DRRX) United States $0.342B 0.00
Harpoon Therapeutics (HARP) United States $0.339B 0.00
Dermira (DERM) United States $0.298B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.298B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.278B 0.00
Ardelyx (ARDX) United States $0.268B 0.00
OptiNose (OPTN) United States $0.266B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.265B 0.00
Molecular Templates (MTEM) United States $0.253B 0.00
Recro Pharma (REPH) United States $0.249B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.230B 0.00
Xeris Pharmaceuticals (XERS) United States $0.208B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.200B 0.00
CV Sciences (CVSI) United States $0.194B 0.00
KalVista Pharmaceuticals (KALV) United States $0.192B 0.00
GlycoMimetics (GLYC) United States $0.189B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.179B 0.00
Nature's Sunshine Products (NATR) United States $0.170B 28.39
AcelRx Pharmaceuticals (ACRX) United States $0.168B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.145B 0.00
Redhill Biopharma (RDHL) Israel $0.143B 0.00
Concert Pharmaceuticals (CNCE) United States $0.139B 0.00
Calithera Biosciences (CALA) United States $0.138B 0.00
IMV INC (IMV) Canada $0.133B 0.00
Ocular Therapeutix (OCUL) United States $0.132B 0.00
Generex Biotechnology (GNBT) United States $0.131B 0.00
CannTrust Holdings (CTST) Canada $0.127B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.125B 0.00
MEI Pharma (MEIP) United States $0.118B 0.00
Jounce Therapeutics (JNCE) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.088B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 33.35
MediWound (MDWD) Israel $0.081B 0.00
Aquestive Therapeutics (AQST) United States $0.079B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.079B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.076B 0.00
Majesco Entertainment (PTE) United States $0.073B 0.00
Neos Therapeutics (NEOS) United States $0.073B 0.00
ElectroCore (ECOR) United States $0.072B 0.00
Lipocine (LPCN) United States $0.068B 0.00
Natural Alternatives (NAII) United States $0.068B 10.16
Otonomy (OTIC) United States $0.066B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
RENEURON GP (RNUGF) United Kingdom $0.065B 0.00
Genocea Biosciences (GNCA) United States $0.063B 0.00
Iterum Therapeutics (ITRM) Ireland $0.063B 0.00
Infinity Pharmaceuticals (INFI) United States $0.062B 0.00
IntelGenx Technologies (IGXT) Canada $0.062B 0.00
Novan (NOVN) United States $0.061B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.058B 0.00
SCYNEXIS (SCYX) United States $0.056B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.056B 1.94
Pharmaxis (PXSLY) Australia $0.055B 0.00
Capnia (SLNO) United States $0.053B 0.00
Melinta Therapeutics (MLNT) United States $0.052B 0.00
Nivalis Therapeutics (ALPN) United States $0.050B 0.00
Aclaris Therapeutics (ACRS) United States $0.049B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
CTI BioPharma (CTIC) United States $0.043B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.042B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.039B 0.00
Mast Therapeutics (SVRA) United States $0.037B 0.00
Jaguar Animal Health (JAGX) United States $0.035B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.033B 0.00
Opexa Therapeutics (ACER) United States $0.029B 0.00
PharmAthene (ALT) United States $0.029B 0.00
Biomerica (BMRA) United States $0.029B 0.00
Bio-Path Holdings (BPTH) United States $0.027B 0.00
China SXT Pharmaceuticals (SXTC) China $0.026B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Heat Biologics (HTBX) United States $0.014B 0.00
Vical (BBI) United States $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Achieve Life Sciences (ACHV) United States $0.013B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Shineco (TYHT) China $0.012B 17.67
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Onconova Therapeutics (ONTX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00